DBVE-PC regimen

Revision as of 14:15, 27 February 2015 by Aparna Vuppala (talk | contribs) (Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} ABVE-PC Regimen; Adriamycin-Bleomycin-Vincristine-Etoposide/Prednisone-Cyclophosphamide Regimen; DBVE-PC; DBVE-PC Regimen; POG...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for DBVE-PC regimen

Articles

Most recent articles on DBVE-PC regimen

Most cited articles on DBVE-PC regimen

Review articles on DBVE-PC regimen

Articles on DBVE-PC regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on DBVE-PC regimen

Images of DBVE-PC regimen

Photos of DBVE-PC regimen

Podcasts & MP3s on DBVE-PC regimen

Videos on DBVE-PC regimen

Evidence Based Medicine

Cochrane Collaboration on DBVE-PC regimen

Bandolier on DBVE-PC regimen

TRIP on DBVE-PC regimen

Clinical Trials

Ongoing Trials on DBVE-PC regimen at Clinical Trials.gov

Trial results on DBVE-PC regimen

Clinical Trials on DBVE-PC regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on DBVE-PC regimen

NICE Guidance on DBVE-PC regimen

NHS PRODIGY Guidance

FDA on DBVE-PC regimen

CDC on DBVE-PC regimen

Books

Books on DBVE-PC regimen

News

DBVE-PC regimen in the news

Be alerted to news on DBVE-PC regimen

News trends on DBVE-PC regimen

Commentary

Blogs on DBVE-PC regimen

Definitions

Definitions of DBVE-PC regimen

Patient Resources / Community

Patient resources on DBVE-PC regimen

Discussion groups on DBVE-PC regimen

Patient Handouts on DBVE-PC regimen

Directions to Hospitals Treating DBVE-PC regimen

Risk calculators and risk factors for DBVE-PC regimen

Healthcare Provider Resources

Symptoms of DBVE-PC regimen

Causes & Risk Factors for DBVE-PC regimen

Diagnostic studies for DBVE-PC regimen

Treatment of DBVE-PC regimen

Continuing Medical Education (CME)

CME Programs on DBVE-PC regimen

International

DBVE-PC regimen en Espanol

DBVE-PC regimen en Francais

Business

DBVE-PC regimen in the Marketplace

Patents on DBVE-PC regimen

Experimental / Informatics

List of terms related to DBVE-PC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: ABVE-PC Regimen; Adriamycin-Bleomycin-Vincristine-Etoposide/Prednisone-Cyclophosphamide Regimen; DBVE-PC; DBVE-PC Regimen; POG 9245 Regimen

Overview

DBVE-PC regimen refers to a regimen consisting of doxorubicin, bleomycin, vincristine, etoposide, prednisone and cyclophosphamide, given in combination with radiation therapy and used for the treatment of high-risk, childhood Hodgkin's lymphoma.[1][2]

Regimen

R – Rituximab

C – Cyclophosphamide

H – Doxorubicin (Hydroxydaunomycin)

O – Vincristine (Oncovin)

P – Prednisone

Indications

References

  1. ↑ "NCI Thesaurus".
  2. ↑ "R-CHOP - National Cancer Institute".
  3. ↑ Coiffier, Bertrand (2002-01-24). "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma". The New England Journal of Medicine. 346 (4): 235–242. doi:10.1056/NEJMoa011795. ISSN 1533-4406. PMID 11807147. Unknown parameter |coauthors= ignored (help)
  4. ↑ Kluin-Nelemans, H. C. (2012-08-09). "Treatment of older patients with mantle-cell lymphoma". The New England Journal of Medicine. 367 (6): 520–531. doi:10.1056/NEJMoa1200920. ISSN 1533-4406. PMID 22873532. Unknown parameter |coauthors= ignored (help)
Retrieved from "https://www.wikidoc.org/index.php?title=DBVE-PC_regimen&oldid=1073888"